UroGen Pharma Ltd. (LSE:0XOD) Financings
Financings
| Raise | Date |
|---|---|
| Strategic investment of equity securities Announced: up to US$7M Buyers: UroGen Pharma Ltd. (up to $7 million in the equity securities of IntraGel) Use of proceeds: Phase 2 clinical development of TumoCure for advanced head and neck cancer | Aug 20, 2026 |